title: 'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohort study.
authors.affiliation: INSERM Research Unit 379, Marseille, France.
authors.forename: S
authors.initials: S
authors.lastname: Duran
authors.forename: C
authors.initials: C
authors.lastname: Solas
authors.forename: B
authors.initials: B
authors.lastname: Spire
authors.forename: M P
authors.initials: MP
authors.lastname: Carrieri
authors.forename: J G
authors.initials: JG
authors.lastname: Fuzibet
authors.forename: D
authors.initials: D
authors.lastname: Costagliola
authors.forename: B
authors.initials: B
authors.lastname: Lacarelle
authors.forename: J P
authors.initials: JP
authors.lastname: Moatti
mesh_terms: D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D002851:Chromatography, High Pressure Liquid; D015331:Cohort Studies; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000097:blood* / Q000627:therapeutic use; D006801:Humans; D019469:Indinavir / Q000097:blood* / Q000627:therapeutic use; D010349:Patient Compliance; D015819:Substance Abuse, Intravenous / Q000150:complications / Q000188:drug therapy*
chemical_list: D017320:HIV Protease Inhibitors; D019469:Indinavir